HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CIR To Hear From P&G Expert With Parabens Re-Review Pending

This article was originally published in The Rose Sheet

Executive Summary

George Daston, Victor Mills Society research fellow at Procter & Gamble, will help the Cosmetic Ingredient Review Expert Panel make sense of recently received developmental and reproductive toxicity (DART) findings as it proceeds with a re-review of parabens' safety.

You may also be interested in...



CIR Panel's Parabens Review Leaning Toward Safe, But 'Insufficient Data' For Now

Cosmetic Ingredient Review’s independent experts will continue to mull new safety information for parabens, as well as input from a P&G expert, but the panel is inclined to determine the preservatives safe as used in an assessment that could differ “significantly” from European conclusions. 

Cosmetics 'Misinformation Madness' Swirls Amid Larger US Trust Crisis

"Misinformation" remains a key challenge for PCPC's advocacy programs and the cosmetics industry in general at a time when consumer trust in US entities – including government, the media, NGOs and business – is down markedly in the US, according to the latest Edelman Trust Barometer.

Cosmetic Ingredient Review Program Will Get 'Fresh Look' In 2018 – PCPC

With federal legislation on the table to task FDA with cosmetic ingredient reviews and provide accredited third parties with the opportunity to inform the agency's assessment work, the Personal Care Products Council plans to give the industry-funded Cosmetic Ingredient Review program a "fresh look."

Related Content

Topics

UsernamePublicRestriction

Register

RS121494

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel